Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation



Status:Completed
Conditions:Peripheral Vascular Disease, Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Cardiology / Vascular Diseases, Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:11/8/2014
Start Date:February 2013
End Date:February 2015

Use our guide to learn which trials are right for you!

Mechanisms of CKD-Induced Foam Cell Formation

There is currently little understanding of macrophage cholesterol homeostasis and foam cell
formation across the spectrum of CKD. We hypothesize that an inverse relationship exist
between the severity of CKD and processes underlying foam cell formation, and that the
relationship becomes independent of serum lipoprotein levels as renal function declines. We
propose to systematically examine scavenger receptors and cholesterol uptake as well as
cholesterol transporters and efflux mechanisms in individuals with normal renal function,
patients with moderate CKD and those with ESRD-HD. We further propose to determine if
processed contributing to foam cell formation are related to the plasma lipid profile and if
the relationship is modified by co-morbidities, such as diabetes, obesity, systemic
inflammation which are common in this population and directly influence vascular integrity.
These data will be critically important to understand when the abnormality starts and will
provide crucial information.


Inclusion Criteria:

Patients with moderate degree of CKD, or patients with advanced CKD who
have progressed to ESRD requiring maintenance dialysis, or control subjects with intact
kidney function

Male or female

All ethnic groups

≥ 18 years and have signed informed consent

For ESRD-HD subjects: > 6 months of hemodialysis

Exclusion Criteria:

Pregnancy and current smoking

BMI > 45

Rheumatoid arthritis and systemic lupus erythematosus

History of active or chronic hepatitis B, history of active or chronic hepatitis C, human
immunodeficiency virus (HIV)

For moderate CKD subjects: nephrotic syndrome

For control subjects: nephrotic syndrome, patients with estimated GFR < 60 mL/min/1.73
m^2, or proteinuria
We found this trial at
1
site
Nashville, Tennessee 37232
?
mi
from
Nashville, TN
Click here to add this to my saved trials